Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study

Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up

(2019) Peter D. Reaven et al.   NEW ENGLAND JOURNAL OF MEDICINE

Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study

(2019) Qiuhong Gong et al.   Lancet Diabetes & Endocrinology

Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988–2014

(2018) Mohammed K Ali et al.   Lancet Diabetes & Endocrinology

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes

(2018) Aidin Rawshani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

(2017) Rury R Holman et al.   Lancet Diabetes & Endocrinology

Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial

(2016) Peter Gæde et al.   DIABETOLOGIA

Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study

(2015) Yali An et al.   DIABETES CARE

Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events

(2015) Jamal S. Rana et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials

(2015) Karen A. Hicks et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes

(2015) Rodney A. Hayward et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study

(2015)   Lancet Diabetes & Endocrinology

Lifestyle and Metformin Interventions Have a Durable Effect to Lower CRP and tPA Levels in the Diabetes Prevention Program Except in Those Who Develop Diabetes

(2014) Ronald B. Goldberg et al.   DIABETES CARE

Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial

(2014) Viveca Ritsinger et al.   Lancet Diabetes & Endocrinology

Metformin-inclusive Therapy Reduces the Risk of Stroke in Patients with Diabetes: A 4-Year Follow-up Study

(2013) Yuan-Yang Cheng et al.   Journal of Stroke & Cerebrovascular Diseases

Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Causal Inference from Longitudinal Studies with Baseline Randomization

(2009) Sengwee Toh et al.  

Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study—Secondary Analysis of the Randomized Trial

(2009) Matti Uusitupa et al.   PLoS One

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

(2008) Guangwei Li et al.   LANCET

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

(2008) William Duckworth et al.   NEW ENGLAND JOURNAL OF MEDICINE